Haemonetics Corp Mass (HAE) Total Assets by Year
Haemonetics Corp Mass closed fiscal year 2026 with $2.4B in total assets, $1.6B in total liabilities and $796.3M in shareholder equity. This represents a decrease of 2.2% from the prior fiscal year. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Haemonetics Corp Mass has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
HAE Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2610-K | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.4B-2.2% | $2.5B+11.6% | $2.2B+13.5% | $1.9B+4.0% | $1.9B+2.2% | $1.8B+43.6% | $1.3B-0.6% | $1.3B+3.0% | $1.2B-0.1% | $1.2B-6.1% | $1.3B-11.2% | $1.5B-1.9% | $1.5B+3.6% | $1.5B+60.5% | $911.1M |
| Total Liabilities | $1.6B-1.9% | $1.6B+31.9% | $1.2B+10.6% | $1.1B+0.6% | $1.1B+2.0% | $1.1B+60.0% | $680.0M+12.0% | $606.9M+25.2% | $484.9M-2.8% | $499.1M-16.5% | $597.6M-9.4% | $659.3M-2.5% | $676.3M-2.4% | $692.7M+288.1% | $178.5M |
| Total Equity | $796.3M-3.0% | $820.8M-14.5% | $960.0M+17.4% | $818.0M+9.2% | $749.4M+2.4% | $731.7M+24.6% | $587.1M-12.1% | $667.9M-11.2% | $752.4M+1.7% | $739.6M+2.5% | $721.6M-12.7% | $826.1M-1.4% | $837.9M+8.9% | $769.2M+5.0% | $732.6M |
HAE Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.4B-3.9% | $2.4B-2.2% | $2.5B-1.6% | $2.4B-3.3% | $2.5B-3.1% | $2.5B+11.6% | $2.5B+15.0% | $2.5B+25.6% | $2.5B+31.3% | $2.2B | $2.2B+17.2% | $2.0B+10.5% |
| Total Liabilities | $1.5B-3.3% | $1.6B-1.9% | $1.6B-2.8% | $1.6B-3.2% | $1.6B-3.4% | $1.6B+31.9% | $1.6B+29.2% | $1.6B+47.3% | $1.6B+46.5% | $1.2B | $1.3B+14.1% | $1.1B+6.4% |
| Total Equity | $837.1M-5.1% | $796.3M-3.0% | $911.5M+0.5% | $849.2M-3.4% | $882.3M-2.5% | $820.8M-14.5% | $906.9M-3.9% | $878.9M-1.7% | $905.4M+10.7% | $960.0M | $943.3M+21.6% | $893.7M+16.0% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Haemonetics Corp Mass financials
Frequently Asked Questions
What was Haemonetics Corp Mass's total assets in fiscal year 2026?
Haemonetics Corp Mass closed fiscal year 2026 with $2.4B in total assets, $1.6B in total liabilities and $796.3M in shareholder equity.
How fast is Haemonetics Corp Mass's total assets growing?
Haemonetics Corp Mass (HAE) total assets fell by 2.2% year over year, from $2.5B to $2.4B in fiscal year 2026.
How has Haemonetics Corp Mass's total assets changed over the years?
Across the 15 fiscal years this page covers, Haemonetics Corp Mass (HAE) total assets went from $911.1M in fiscal year 2012 to $2.4B in fiscal year 2026.
What was Haemonetics Corp Mass's total assets in the most recent quarter?
Haemonetics Corp Mass (HAE) reported $2.4B in total assets in Q1 2027. This represents a decrease of 3.9% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Haemonetics Corp Mass (HAE) reported on that line in every period on record.